Why Attend
With the neurological drug market now worth $86 billion, and the FDA set to reach a decision on Biogen’s Acudanimib in Spring, whether you’re focused on oncology, Alzheimer’s or ALS, it’s an exciting time to be targeting misfolding diseases.
Though there are currently no therapies and cures in this area of drug discovery due to several unmet drug discovery needs. The inaugural Targeting Protein Misfolding Congress will bring together academic and industry leaders, such as Anavex, Ionis Pharmaceuticals, Wren Therapeutics, Ariona State University and University of Florida, who are building platforms to identify and validate targets in protein misfolding diseases and intrinsically disordered proteins to combat these challenges:
- The lack of appropriate disease models, physiological assays and blood biomarkers to evaluate translation aspects and target engagement.
- Delivery mechanisms to deliver small molecules and biologics across the blood brain barrier.
- Determining the true drivers and toxic species in protein misfolding diseases.
- Mapping the druggable hotspots on protein aggregates and intrinsically disordered proteins to target with small molecules.
Key outcomes this year include:
- Improve pre-clinical predictability by learning what disease models are now considered best practice with Beth Hoffman, Founder and CEO, Origami Therapeutics and understand how Pfizer develops physiologically relevant assays for phenotypic screening.
- Understand the underlying chemical biology of protein aggregation and the drivers behind misfolding diseases to help inform your target validation with Peter Lansbury, CSO, Lysosomal Therapeutics
- Learn about the latest developments in delivery of biologics across the blood brain barrier as well as viral delivery advancements with Laura Ranum, Professor, University of Florida
- Target your aggregate of choice after hearing Behnam Nabet, Research Fellow, Dana Farber Cancer Institute discuss novel approaches involving degradation
Speakers
Johanne Kaplan
Abhishek Singharan
Tiago Outeiro
Jack Rogers
Alberto Perez
Laura Ranum
Fabien Vincent
Peter Lansbury
Beth Hoffman
Gene Yeo
Hien Zhao
Alexander Scheer
Chris Missling
Rick Morimoto
Michele Vendruscolo
Judith Frydman
Gergely Toth
Mark Reed
Behnam Nabet
Get access to 2 conferences for the price of 1!
The Targeting Protein Misfolding Congress is co-locating virtually with the Targeting RNA Congress in March this year! Book your place on the Targeting Protein Misfolding Summit and get full access to the Targeting RNA Congress's content.
Key Speakers at the Targeting RNA include:
- Jay Schneekloth, Principle Investigator, NIH
- Craig Blain, Associate Director of Biochemistry, Arrakis Therapeutics
- Silvi Rouskin, Whitehead fellow, MIT
- Amanda Garner, Associate Professor, University of Michigan
- Matt Disney, Co-Founder and Professor, Expansion therapeutics and Scripps Research Institute
- Gene Yeo, Professor of Cellular and Molecular Medicine UCSD
Sponsors
Become a Sponsor
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.